Harmony Asset Management LLC Takes $929,000 Position in iShares Biotechnology ETF $IBB

Harmony Asset Management LLC bought a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, Holdings Channel reports. The fund bought 5,502 shares of the financial services provider’s stock, valued at approximately $929,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Dynamic Wealth Strategies LLC grew its position in shares of iShares Biotechnology ETF by 16.6% during the 4th quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock valued at $71,000 after acquiring an additional 60 shares during the period. Flagship Private Wealth LLC grew its position in shares of iShares Biotechnology ETF by 2.0% during the 4th quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock valued at $521,000 after acquiring an additional 60 shares during the period. Larson Financial Group LLC grew its position in shares of iShares Biotechnology ETF by 2.3% during the 4th quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock valued at $458,000 after acquiring an additional 60 shares during the period. Webster Bank N. A. grew its position in shares of iShares Biotechnology ETF by 1.0% during the 4th quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock valued at $1,093,000 after acquiring an additional 62 shares during the period. Finally, Choreo LLC grew its position in shares of iShares Biotechnology ETF by 2.2% during the 4th quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock valued at $514,000 after acquiring an additional 65 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $167.91 on Thursday. The firm has a 50 day moving average price of $169.01 and a 200-day moving average price of $169.83. iShares Biotechnology ETF has a twelve month low of $119.78 and a twelve month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a dividend of $0.1218 per share. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.